• Scott Clendaniel

Health Care Reform Updates

Trump Signs Executive Orders to Lower Drug Prices

  • July 28, 2020

  • Special News Alerts

Series of Four Executive Orders Issued On July 24, 2020, President Donald Trump issued the following series of executive orders in an effort to lower drug prices: 

  • Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen: directs federally qualified health centers to pass along massive discounts on insulin and epinephrine received from drug companies to certain low-income Americans.

  • Executive Order on Increasing Drug Importation to Lower Prices for American Patients: intended to allow state plans for safe importation of certain drugs, authorize the re-importation of insulin products made in the United States, and create a pathway for widespread use of personal importation waivers at authorized pharmacies in the United States.

  • Executive Order on Access to Affordable Life-saving Medications: intended to prohibit secret deals between drug manufacturers and pharmacy benefit manager middlemen, ensuring patients directly benefit from available discounts at the pharmacy counter. 

President Trump also announced a fourth executive order intended to ensure that the United States pays the lowest price available in economically comparable countries for Medicare Part B drugs. However, the order's implementation is delayed until Aug. 25, 2020, to give pharmaceutical executives a chance to propose an alternative.

United Benefits Partners, Inc.

United Benefits Partners is an innovative employee benefits marketing firm that combines senior level carrier knowledge with modern technology and service platforms to create a complete benefits experience.

  • Facebook
  • Twitter
  • LinkedIn
Contact us

Address: 3000 Atrium Way, Suite 200
Mount Laurel, NJ 08054

Email: info@ubpbenefits.com

Phone: 856-345-0355

Fax: 856-200-8635

Sign up

Sign up to get the latest news.

© 2020 United Benefits Partners, Inc. | Designed By Donchid